Clinical trials and progress with paclitaxel in ovarian cancer
about
Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner.Transcriptome sequencing and identification of cold tolerance genes in hardy Corylus species (C. heterophylla Fisch) floral budsTranscriptome analyses of a Chinese hazelnut species Corylus mandshuricaExpression and Functional Analysis of WRKY Transcription Factors in Chinese Wild Hazel, Corylus heterophylla FischEffect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo.Elevated AKAP12 in paclitaxel-resistant serous ovarian cancer cells is prognostic and predictive of poor survival in patients.Advantages of the avian model for human ovarian cancerThe duplicitous origin of ovarian cancer.Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan.Tumor Targeting via Integrin Ligands.Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1).Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function.Preparation of sodium cholate-based micelles through non-covalent ıbonding interaction and application as oral delivery systems for paclitaxel.Synergistic antitumor effect of combining metronomic chemotherapy with adoptive cell immunotherapy in nude mice.Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer.Efficient induction of apoptosis in cancer cells by paclitaxel-loaded selenium nanoparticles.Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models.99mTc-Glucarate for assessment of paclitaxel therapy in human ovarian cancer in mice.Fatal poisoning with Taxus baccata: quantification of paclitaxel (taxol A), 10-deacetyltaxol, baccatin III, 10-deacetylbaccatin III, cephalomannine (taxol B), and 3,5-dimethoxyphenol in body fluids by liquid chromatography-tandem mass spectrometry.Studies of the precipitation pattern of paclitaxel in intravenous infusions and rat plasma using laser nephelometry.
P2860
Q30640795-E6947CEC-2AB3-4153-BBFE-995F64661EBAQ34277379-572BDE29-1A98-434E-B594-52C43DC415D9Q35008029-D4F7E3B7-CF7D-4329-8CB4-8BB4F7238706Q35744990-C5854BF0-4DCC-4E35-B08D-32EEF4A5095CQ36099292-92277BCC-9D3A-451E-AD65-FB64A22E7E80Q36182116-6B52B7B3-A2B0-4B76-8321-40D8179D9B67Q36334681-DFDC75D3-99B0-4F8B-9994-DBF6F780379BQ36919484-2416F9CC-5D45-4F9C-BADE-742568C5F97AQ37249302-35B19CB4-24DE-46F0-87F5-8D3642391E87Q38134759-7FF02211-E856-4E76-890A-F658BDC04ADCQ38394240-EE2EA822-F18D-4E39-8ADD-6A067BDF3436Q38599086-544DD7E3-C110-4C57-83A2-656F05CF97F6Q38741030-CCA15F23-FF3A-4788-B10B-E7790A982E7BQ39015610-3B28D26C-F4A8-4929-AC4F-B4D93BBFDD6BQ41421955-B35E9B67-6E7D-4DEF-BF8A-A2807D4B0E62Q41897007-DA13DCC9-12C6-4A31-87C6-1743166B3C36Q46281941-3D1DC622-43CF-4F69-868F-BD9E05259524Q47141265-566AC4DE-40E5-4E9A-9A0D-8C9566CAD185Q48522871-47A986A1-CD47-4757-8DC5-B3DC2FA16BE2Q48683720-54DEFE6D-DF74-4B5F-835A-47B2ADDC5D9FQ50897687-15A59640-340B-4FD3-B56A-B73A4238914C
P2860
Clinical trials and progress with paclitaxel in ovarian cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical trials and progress with paclitaxel in ovarian cancer
@ast
Clinical trials and progress with paclitaxel in ovarian cancer
@en
Clinical trials and progress with paclitaxel in ovarian cancer
@nl
type
label
Clinical trials and progress with paclitaxel in ovarian cancer
@ast
Clinical trials and progress with paclitaxel in ovarian cancer
@en
Clinical trials and progress with paclitaxel in ovarian cancer
@nl
prefLabel
Clinical trials and progress with paclitaxel in ovarian cancer
@ast
Clinical trials and progress with paclitaxel in ovarian cancer
@en
Clinical trials and progress with paclitaxel in ovarian cancer
@nl
P2093
P2860
P356
P1476
Clinical trials and progress with paclitaxel in ovarian cancer
@en
P2093
Adnan Munkarah
Christopher Bryant
Gunjal Garg
Haider Mahdi
Jay P Shah
Sanjeev Kumar
P2860
P304
P356
10.2147/IJWH.S7012
P407
P577
2010-11-19T00:00:00Z